Pharming Group to report first quarter 2024 financial results on May 8
April 24 2024 - 2:00AM
Pharming Group to report first quarter 2024 financial results on
May 8
Leiden, the Netherlands, April 24, 2024:
Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq:
PHAR) confirms it will report its preliminary (unaudited) first
quarter 2024 financial results, for the period ended March 31, on
Wednesday, May 8, 2024.
Pharming will host a presentation for analysts
and investors at 13:30 CEST/07:30 am EDT on May 8, 2024.
To participate in the conference call, please
register in advance using the link below. Once registered, dial-in
information and a unique PIN will be provided, allowing access to
the call.
Conference call
registration:
Please note, the Company will only take
questions from dial-in attendees.
https://register.vevent.com/register/BI6f55067b569a46d7a67be9f94edefc95
To watch the live webcast, please register in
advance using the link below.
Webcast registration:
https://edge.media-server.com/mmc/p/ov2ruv3b
About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam:
PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated
to transforming the lives of patients with rare, debilitating, and
life-threatening diseases. Pharming is commercializing and
developing an innovative portfolio of protein replacement therapies
and precision medicines, including small molecules, biologics, and
gene therapies that are in early to late-stage development.
Pharming is headquartered in Leiden, the Netherlands, and has
employees around the globe who serve patients in over 30 markets in
North America, Europe, the Middle East, Africa, and
Asia-Pacific.
For more information, visit www.pharming.com and
find us on LinkedIn.
For further public information,
contact:
Pharming Group, Leiden, The
NetherlandsMichael Levitan, VP Investor Relations &
Corporate CommunicationsT: +1 (908) 705 1696E:
investor@pharming.com
FTI Consulting, London, UKVictoria
Foster Mitchell/Alex Shaw/Amy ByrneT: +44 203 727 1000
LifeSpring Life Sciences Communication,
Amsterdam, The NetherlandsLeon MelensT: +31 6 53 81 64
27E: pharming@lifespring.nl
Pharming Group NV (EU:PHARM)
Historical Stock Chart
From Oct 2024 to Nov 2024
Pharming Group NV (EU:PHARM)
Historical Stock Chart
From Nov 2023 to Nov 2024